CoChat

Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease

Open access
Li, Man, Duan, Lei, Cai, Yu-Lun, Li, Hui-Ying, Hao, Ben-Chuan, Chen, Jian-Qiao, Liu, Hong-Bin · 2020 · Cardiovascular Diabetology

Published version of a preprint

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.

Abstract

Background: Growth differentiation factor-15 (GDF-15) is a marker of inflammation, oxidative stress and it is associated with adverse prognosis in cardiovascular disease. The aim of the present cohort study is to investigate the prognostic value of GDF-15 in patients with coronary artery disease (CAD) during long-term follow up. Methods: A total of 3641 consecutive patients with CAD were prospectively enrolled into the study and followed up for major adverse cardiovascular events (MACEs) and all-cause death up to 5.3–7.6 years. Plasma GDF-15 was measured and clinical data and long-term events were registered. The patients were subsequently divided into three groups by the levels of GDF-15 and the prognostic value of GDF-15 level with MACEs and all-cause death was evaluated. Results: After a median follow-up at 6.4 years later, 775 patients (event rate of 21%) had developed MACEs and 275 patients died (event rate of 7.55%). Kaplan–Meier analysis indicated that the patients with GDF-15 > 1800 ng/L were significantly associated with an increased risk of MACEs and all-cause death. Cox regression analysis indicated that GDF-15 > 1800 ng/L were independently associated with the composite of MACEs (HR 1.74; 95% CI 1.44–2.02; P < 0.001) and all-cause death (HR 2.04; 95% CI 1.57–2.61; P < 0.001). For MACEs, GDF-15 significantly improved the C-statistic (area under the curve, 0.583 [95% CI 0.559–0.606] to 0.628 [0.605–0.651]; P < 0.001), net reclassification index (0.578; P = 0.031), and integrated discrimination index (0.021; P = 0.027). For all-cause death, GDF-15 significantly improved the C-statistic (0.728 [95% CI 0.694–0.761] to 0.817 [0.781–0.846]; P < 0.001), net reclassification index (0.629; P = 0.001), and integrated discrimination index (0.035; P = 0.002). Conclusions: In the setting of CAD, GDF-15 is associated with long-term MACEs and all-cause death, and provides incremental prognostic value beyond traditional risks factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-020-01092-7

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of the study
Fig. 1 Flowchart of the studyCC BY · PubMed Central
Fig. 2 Kaplan–Meier analysis according to different levels of GDF-15
Fig. 2 Kaplan–Meier analysis according to different levels of GDF-15CC BY · PubMed Central
Fig. 3 Comparison of different predictive models for predicting MACEs (a) and all-cause death (b)
Fig. 3 Comparison of different predictive models for predicting MACEs (a) and all-cause death (b)CC BY · PubMed Central
Fig. 4 Accumulative MACEs (a) and death events (c) on 6 months, 12 months and 72 months, the MACEs (b) and death rates (d) during 0–6 months, 6–12 months and 12–72 months
Fig. 4 Accumulative MACEs (a) and death events (c) on 6 months, 12 months and 72 months, the MACEs (b) and death rates (d) during 0–6 months, 6–12 months and 12–72 monthsCC BY · PubMed Central
Fig. 5 Kaplan-Meier analysis on 6 months, 12 months and 72 months according to different levels of GDF-15
Fig. 5 Kaplan-Meier analysis on 6 months, 12 months and 72 months according to different levels of GDF-15CC BY · PubMed Central
Fig. 6 Hazard ratios, 95% confidence intervals (CI) according to values of GDF-15
Fig. 6 Hazard ratios, 95% confidence intervals (CI) according to values of GDF-15CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 72

Metadata

Authors
Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B.
Affiliations
Chinese PLA General Hospital (CN)
Venue
Cardiovascular Diabetology
Published
2020-08-03
Volume
19
Issue
1
Pages
120-120
ISSN
1475-2840 (ISSN-L)
OpenAlex
W3047598126
Cited by
71
References
67
Citations by year
2026: 15 · 2025: 18 · 2024: 16 · 2023: 12 · 2022: 5 · 2021: 4 · 2020: 1
FWCI
4.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Key Projects of Logistics Scientific Research Project of Chinese PLA (17BJZ48)
  • National Key Research Program of China (2017YFC0840103)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
growth differentiation factor 15, coronary artery disease, major adverse cardiovascular events, all-cause mortality, prognostic factors, inflammation, oxidative stress, risk stratification, risk reclassification, plasma biomarkers, long-term follow-up, cardiovascular risk prediction
MeSH terms
Adult, Aged, Aged, 80 and over, Cause of Death, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Risk Assessment, Growth Differentiation Factor 15

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease. https://app.cochat.ai/papers/10.1186/s12933-020-01092-7
The paper
Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B. (2020). Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-020-01092-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.